EUVIMEDEUVIMED entdecken
Open Access

Characterization of Serotype-Specific Dengue Virus T-Cell Inhibition

Jinhua Xiang, James H McLinden, Qing Chang, Micaela Fosdick, Hillel Haim, Alexander Ploss, Wesley Hottel, Nirjal Bhattarai, Tomokazu Tamura, Jiayu Zhang, Jon C D Houtman, Jack T Stapleton iD

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiaf241 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Jinhua Xiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medical and Research Services, Iowa City VA HealthCare. Hauptthemen laut MEDLINE: Dengue Virus, Receptors, Antigen, T-Cell, Dengue, T-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: University of Iowa Carver College of Medicine, BLRD VA, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dengue virus serotype 2 and 3 (DENV-2 and -3) infections are associated with more severe disease outcomes than DENV-1 and 4, though a biological explanation for this has not been identified.

Methods

DENV serotype effects on human T-cell activation were assessed by measuring T-cell receptor (TCR)–mediated interleukin 2 release following TCR stimulation. DENV envelope (env) proteins were expressed in Jurkat CD4+ T-cell lines, and regions inhibiting TCR inhibition were mapped by mutagenesis. TCR signaling pathway inhibition was characterized by total internal reflection fluorescence microscopy and immunoblot. Reverse genetics validated env mapping results.

Results

T-cell incubation with DENV-1 and -4 inhibited TCR signaling, whereas DENV-2 and -3 did not. Inhibition did not require viral replication. DENV env protein expression inhibited TCR by interfering with activation of proximal TCR signaling events. Amino acids (aa's) 49 to 62 of DENV 1 env were sufficient to inhibit TCR signaling, with env aa's 55 and 66 being critical. Reverse genetics confirmed that substitution of DENV-2 and -3 aa's 55 and 66 into DENV-1 and -4 reversed TCR inhibition and that DENV-1 aa's 55 and 66 introduced into DENV-2 and -3 enabled TCR inhibition.

Conclusions

DENV-2 and -3 are associated with more severe clinical disease than DENV-1 and -4; however, no biological explanation for this difference has been previously identified. We found that DENV-1 and -4 viral particles and env proteins blunt T-cell responses by interfering with proximal TCR signaling, while DENV-2 and -3 do not, potentially explaining DENV pathogenic outcomes in primary and secondary infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dengue VirusReceptors, Antigen, T-CellDengueT-LymphocytesHumansSerogroupJurkat CellsViral Envelope ProteinsSignal TransductionLymphocyte ActivationCD4-Positive T-LymphocytesVirus Replication

Stichwörter der Autor:innen

T-cell receptordengue virusflavivirusserotypesignaling

Substanzen

Receptors, Antigen, T-CellViral Envelope Proteins

Autor:innen und Institutionen

  • Medical and Research Services, Iowa City VA HealthCare.
  • Department of Internal Medicine.
  • Department of Microbiology and Immunology, University of Iowa, Iowa City.
  • Department of Molecular Biology, Princeton University, New Jersey.
  • State Hygienic Laboratory, University of Iowa, Iowa City.
  • Office of Therapeutic Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.

ORCID-Profile: Jack T Stapleton

Förderung

  • University of Iowa Carver College of Medicine
  • BLRD VA
  • NIAID NIH HHS
  • predoctoral fellowship by the China Research Council
  • NIH HHS
  • NCI NIH HHS
  • Human Immunology Core, University of Iowa
  • Veterans Affairs VA SeqCURE program

Zitieren

APA

Xiang, J., McLinden, J. H., Chang, Q., Fosdick, M., Haim, H., Ploss, A., Hottel, W., Bhattarai, N., Tamura, T., Zhang, J., Houtman, J. C. D., & Stapleton, J. T. (2025). Characterization of Serotype-Specific Dengue Virus T-Cell Inhibition. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf241

Vancouver

Xiang J, McLinden JH, Chang Q, Fosdick M, Haim H, Ploss A, et al. Characterization of Serotype-Specific Dengue Virus T-Cell Inhibition. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf241

BibTeX
@article{Xiang2025,
  author = {Xiang, Jinhua and McLinden, James H and Chang, Qing and Fosdick, Micaela and Haim, Hillel and Ploss, Alexander and Hottel, Wesley and Bhattarai, Nirjal and Tamura, Tomokazu and Zhang, Jiayu and Houtman, Jon C D and Stapleton, Jack T},
  title = {Characterization of Serotype-Specific Dengue Virus T-Cell Inhibition},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiaf241}
}
Kostenlos starten →